Literature DB >> 3327420

Lipid emulsions as drug delivery systems.

S S Davis1, C Washington, P West, L Illum, G Liversidge, L Sternson, R Kirsh.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3327420     DOI： 10.1111/j.1749-6632.1987.tb45793.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  14 in total

1.  Amphotericin B in lipid emulsion: stability, compatibility, and in vitro antifungal activity.

Authors:  S Walker; S A Tailor; M Lee; L Louie; M Louie; A E Simor
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 2.  Pharmacology and toxicology of novel drug delivery systems. Regulatory issues.

Authors:  J Weissinger
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

3.  Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs.

Authors:  E Merisko-Liversidge; P Sarpotdar; J Bruno; S Hajj; L Wei; N Peltier; J Rake; J M Shaw; S Pugh; L Polin; J Jones; T Corbett; E Cooper; G G Liversidge
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

4.  Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles.

Authors:  Jian You; Jun Zhao; Xiaoxia Wen; Chunhui Wu; Qian Huang; Fada Guan; Richard Wu; Dong Liang; Chun Li
Journal:  J Control Release       Date:  2015-01-28       Impact factor: 9.776

5.  Venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats following intravenous administration of a novel supersaturated submicron lipid emulsion.

Authors:  Y Wang; G M Mesfin; C A Rodríguez; J G Slatter; M R Schuette; A L Cory; M J Higgins
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

6.  A novel in vitro release method for submicron sized dispersed systems.

Authors:  N Chidambaram; D J Burgess
Journal:  AAPS PharmSci       Date:  1999

Review 7.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

8.  Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride.

Authors:  H Heiati; N C Phillips; R Tawashi
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

9.  Structure-activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose.

Authors:  I Gruda; D Milette; M Brother; G S Kobayashi; G Medoff; J Brajtburg
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

10.  Fat emulsions based on structured lipids (1,3-specific triglycerides): an investigation of the in vivo fate.

Authors:  H Hedeman; H Brøndsted; A Müllertz; S Frokjaer
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.